mds
Showing 1 - 25 of 108
AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)
Recruiting
- AML
- MDS
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital
Nov 30, 2023
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
AML, MDS Trial in Tianjin (XZB-0004)
Not yet recruiting
- AML
- MDS
-
Tianjin, Tianjin, ChinaHematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Orca-T
- Standard-of-Care
-
Duarte, California
- +13 more
Jan 25, 2023
MDS Trial (Yisui granule, Placebo)
Not yet recruiting
- MDS
- Yisui granule
- Placebo
- (no location specified)
Jan 13, 2023
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)
Not yet recruiting
- Leukemia, Myeloid, Acute
- +3 more
- Venetoclax plus RIC
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Oct 12, 2022
Lower-risk MDS Patients
Recruiting
- MDS
-
Leipzig, GermanyUniversity Hospital Leipzig
Oct 13, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD Trial in Austria, Germany, Italy
Recruiting
- Mitochondrial Diseases
- +17 more
-
Innsbruck, Austria
- +18 more
Sep 23, 2022
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)
Recruiting
- Graft Vs Host Disease
- +5 more
- Cyclophosphamide
- ATG
-
Augsburg, Germany
- +15 more
Aug 2, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)
Not yet recruiting
- MDS
- AML
- venetoclax + azacitidine +/- donor lymphocyte infusion
-
Amiens, France
- +13 more
Jul 21, 2022
MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)
Terminated
- MDS
- Myelodysplastic Syndromes
- APR-548 + Azacitidine
-
Tampa, Florida
- +3 more
Jul 20, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- CFI-400945
- +2 more
-
Duarte, California
- +7 more
Jul 20, 2022